Climaco John M
- SEC CIK
- 0001546797
No open-market purchases or sales filed in the past year.
Current role at each company
- CNSP CNS Pharmaceuticals, Inc.Chief Executive Officeras of Nov 19, 2025
- MBRX Moleculin Biotech, Inc.Directoras of Nov 14, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Climaco John M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CNSP CNS Pharmaceuticals, Inc.
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2023 (view filing) | Apr 12 | 2 days | Climaco John MChief Executive Officer | PPurchase | +15.0K | $0.69 | +$10.3K | +50.0%45.0K after | |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Climaco John MChief Executive Officer | PPurchase | +2.75K | $1.80 | +$4.95K | +5.9%49.0K after | |
| Feb 6, 2024 (view filing)10:27 AM ET | Feb 1 | 5 daysLate | Climaco John MChief Executive Officer | PPurchase | +166.7K | $0.30 | +$50.0K | +340.1%215.7K after |